New research and clinical evidence are redefining how clinicians detect and manage preeclampsia, with angiogenic biomarker testing offering earlier, clearer insight into maternal risk
Every biomarker in Aliri’s study-ready panels is carefully selected and rigorously verified for its intended biological context
Yao Chen of Sanofi shares how her team achieves sensitivity, specificity, precision, and robustness in protein biomarker detection
MOBILion Systems has shown how its proprietary PAMAF™ mode of high‑resolution ion mobility can reshape mass‑spectrometry‑based proteomics
Myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities
University of Cambridge researcher spotlights a novel radiotracer during ELRIG Drug Discovery 2025
Enables ultra-low variant detection across a range of key measurable residual disease targets in acute myeloid leukaemia, including very large FLT3-ITDs
Dr. Richard Knight, medical director of transplant diagnostics at Thermo Fisher Scientific explores personalized, non‑invasive approaches designed to improve transplant success
Quanterix Director of Medical Affairs discusses the advances revolutionizing Alzheimer’s diagnosis and care
Neuro-Bio is creating a first-of-its-kind diagnostic, targeting a novel biomarker in Alzheimer’s Disease
This assay allows for the quantitative measurement of soluble sTREM2 in human cerebrospinal fluid and blood within just 35 minutes
Radiometer’s blood gas and immunoassay POC analysers deliver critical parameters enabling critical care teams to make quick decisions fast
Accelerated platform delivers validated biomarkers with ready-to-use Optimer ligands in months rather than years
Revvity’s Euroimmun shares insights on the role of amyloid-beta, tau, and neurofilament in Alzheimer’s disease diagnostics
Join experts as they discuss the significant hurdles in spatial proteomics and how innovative tools such as the EVOS S1000 Spatial Imaging System are set to redefine research capabilities in this rapidly evolving field
From concept to clinic, NExT gives researchers and developers access to Fujirebio’s unmatched expertise in neurological biomarker testing
Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa technology included in more than 55 posters and oral presentations at the annual conference demonstrating its impact on neurodegenerative disease research
The test operates using the company’s fully automated Lumipulse G1200 instrument system
Crown Bioscience to deliver clinical-grade testing, further strengthening its support for clients' clinical and translational drug development efforts
By developing rapid, accurate, and cost-effective lateral flow tests for prostate cancer, Valley Diagnostics aims to make early diagnosis more accessible and reliable
Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform
Agreement represents a significant step towards bringing Sona’s bTB rapid test to the market at scale
The use of protein biomarkers in oncology is growing rapidly and offers real hope to patients with hard-to-treat cancers
The first cleared troponin assay in the U.S. for longer-term prognostic insights
